tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

XGN Stock Latest News

Exagen’s Strategic Growth and Innovation Drive Buy Rating Amid Market Expansion
RatingsExagen’s Strategic Growth and Innovation Drive Buy Rating Amid Market Expansion
18d ago
XGN
Exagen management to meet virtually with B. Riley
PremiumThe Fly
Exagen management to meet virtually with B. Riley
22d ago
XGN
Exagen price target raised to $15 from $13 at BTIG
PremiumThe Fly
Exagen price target raised to $15 from $13 at BTIG
26d ago
XGN
Exagen price target raised to $18 from $15 at B. Riley
PremiumThe Fly
Exagen price target raised to $18 from $15 at B. Riley
1M ago
XGN
Exagen Inc. Reports Strong Q3 2025 Performance
PremiumCompany Announcements
Exagen Inc. Reports Strong Q3 2025 Performance
1M ago
XGN
Exagen’s Earnings Call: Growth Amid Financial Hurdles
PremiumCompany AnnouncementsExagen’s Earnings Call: Growth Amid Financial Hurdles
1M ago
XGN
Exagen’s Growth Potential Amid ASP Challenges: A Positive Long-Term Investment Outlook
Premium
Ratings
Exagen’s Growth Potential Amid ASP Challenges: A Positive Long-Term Investment Outlook
1M ago
XGN
Exagen’s Strong Volume Growth and Market Penetration Support Buy Rating Despite Temporary ASP Setbacks
Premium
Ratings
Exagen’s Strong Volume Growth and Market Penetration Support Buy Rating Despite Temporary ASP Setbacks
1M ago
XGN
Exagen reports Q3 EPS (31c), consensus (16c)
PremiumThe Fly
Exagen reports Q3 EPS (31c), consensus (16c)
1M ago
XGN
Exagen reiterates FY25 revenue view $65M-$70M, consensus $67.48M
PremiumThe Fly
Exagen reiterates FY25 revenue view $65M-$70M, consensus $67.48M
1M ago
XGN
Exagen (XGN) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Exagen (XGN) Q3 Earnings Cheat Sheet
1M ago
XGN
Exagen price target raised to $15 from $11 at Canaccord
PremiumThe Fly
Exagen price target raised to $15 from $11 at Canaccord
1M ago
XGN
Exagen price target raised to $15 from $12 at KeyBanc
PremiumThe FlyExagen price target raised to $15 from $12 at KeyBanc
2M ago
XGN
Exagen initiated with a Buy at B. Riley
Premium
The Fly
Exagen initiated with a Buy at B. Riley
3M ago
XGN
Exagen’s Legal Challenges: Potential Risks to Financial Stability and Market Position
Premium
Company Announcements
Exagen’s Legal Challenges: Potential Risks to Financial Stability and Market Position
4M ago
XGN
Exagen Inc. Reports Record Revenue Amidst Growth Challenges
PremiumCompany Announcements
Exagen Inc. Reports Record Revenue Amidst Growth Challenges
4M ago
XGN
Exagen price target raised to $10 from $7 at Cantor Fitzgerald
PremiumThe Fly
Exagen price target raised to $10 from $7 at Cantor Fitzgerald
4M ago
XGN
Exagen price target raised to $11 from $8 at Canaccord
PremiumThe Fly
Exagen price target raised to $11 from $8 at Canaccord
4M ago
XGN
Exagen’s Strong Q2 Performance and Growth Strategy Justify Buy Rating
PremiumRatings
Exagen’s Strong Q2 Performance and Growth Strategy Justify Buy Rating
4M ago
XGN
KeyBanc upgrades Exagen on improved revenue visibility
PremiumThe FlyKeyBanc upgrades Exagen on improved revenue visibility
4M ago
XGN
Exagen Inc. Reports Record Q2 2025 Revenue
Premium
Company Announcements
Exagen Inc. Reports Record Q2 2025 Revenue
4M ago
XGN
Exagen’s Promising Financial Trajectory and Raised Price Target Amid Strong Performance and Strategic Growth Initiatives
Premium
Ratings
Exagen’s Promising Financial Trajectory and Raised Price Target Amid Strong Performance and Strategic Growth Initiatives
4M ago
XGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >